Neurava is a MedTech startup developing first-of-its-kind smart wearables capable of identifying and alerting for seizures, cardiorespiratory dysfunctions, and impending SUDEP risk. This diagnostic platform, pioneered by the company's founders, can have a lifesaving impact on the millions of people worldwide who suffer from epilepsy.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/03/24 | $2,000,000 | Series A |
Elevate Ventures First Leaf Capital Life Science Angels  Purdue Innovates Rivermount Ventures UCB | undisclosed |
